Consumer sequencing startup hope to rival 23andMe
/A Silicon Valley startup just launched a DNA-based health test that could be a big competitor to 23andMe
On Tuesday, DNA testing startup Helix launched a new test that looks at your risk of diseases like breast cancer, colon cancer, and high cholesterol.
You can buy the test online for $260, but it must be approved by a physician.
Helix partnered with clinical diagnostics company PerkinElmer to create the test, which includes genetics counseling.
The test also uses a type of sequencing that some experts say all DNA-based health tests should use.
READ MORE … and HERE …
